TOPADUR Pharma AG, located in Schlieren, was founded in 2015 by experienced R&D scientists. Topadur discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, Alopecia and skin aging.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    10-19
Key business

You may also be interested in